Modeling the Development of <i>SRSF2</i> Mutated Myeloid Malignancies By CRISPR/Cas9 Mediated Genome Engineering of Primary Human Hematopoietic Stem and Progenitor CellsGabriel Pabst, Andreas Reinisch, Johannes Foßelteder et al.|Blood|2021Cited by 4
Data from The Cell Type–Specific 5hmC Landscape and Dynamics of Healthy Human Hematopoiesis and <i>TET2</i>-Mutant PreleukemiaYusuke Nakauchi, Ravindra Majeti, Armon Azizi et al.|Unknown|2023Cited by 0
Data from The Cell Type–Specific 5hmC Landscape and Dynamics of Healthy Human Hematopoiesis and <i>TET2</i>-Mutant PreleukemiaYusuke Nakauchi, Ravindra Majeti, Armon Azizi et al.|Unknown|2023Cited by 0
Supplementary Figure from The Cell Type–Specific 5hmC Landscape and Dynamics of Healthy Human Hematopoiesis and <i>TET2</i>-Mutant PreleukemiaYusuke Nakauchi, Ravindra Majeti, Armon Azizi et al.|Unknown|2023Cited by 0
Supplementary Table from The Cell Type–Specific 5hmC Landscape and Dynamics of Healthy Human Hematopoiesis and <i>TET2</i>-Mutant PreleukemiaYusuke Nakauchi, Ravindra Majeti, Armon Azizi et al.|Unknown|2023Cited by 0